| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |